Skip to content

Constipation Relieving Herbal Syrup for Children aged 3 to 12 years.

An Open label, Four Arm, Parallel Clinical Study to Evaluate the Efficacy and Safety of HCLX031706 for the symptomatic relief of Functional Constipation in Pediatric Population

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020576
Enrollment
28
Registered
2019-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K590- Constipation

Interventions

Intervention1: HCLX031706: Herbal syrup for treating constipation for children aged 3 to 12 years Intervention2: HCLX031706: herbal laxative syrup to drink orally to relieve constipation for children

Sponsors

The Himalaya Drug Company
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Paediatric subjects aged between >=3 years to 2. Pediatric subjects clinically diagnosed with Functional Constipation as per ROME III criteria. 3. Parents/caregivers willing to consent for the participation of their child. 4. Child >= 7 years willing to assent for its participation in the study.

Exclusion criteria

Exclusion criteria: 1. Pediatric subjects with any clinically significant systemic illness requiring long term medication. 2. A known history or present condition of allergic response to products its components or to any of the ingredients in the test product 3. Pediatric Subjects treated with any laxatives, 2 weeks prior to screening and are experiencing the laxative effect. 4. Pediatric Subjects on any drugs which can induce constipation especially opioid induced constipation (OIC) will be excluded

Design outcomes

Primary

MeasureTime frame
Increase in the total number of stools per day at day 7 as compared to baseline. Improvement in the stool consistency at day 7 as compared to baseline Timepoint: 7 Days Study. To Check the overall improvement from day 1 to Day 7.

Secondary

MeasureTime frame
Global assessment of efficacy based on the evaluation of severity of functional constipation as compared to the baseline using the 4-point rating scale as below; Improvement in the associated symptoms like irritability, loss of appetite and abdominal bloating at the end of the study or the early satiety(which disappear following the passage of a large stool Timepoint: 7 days

Countries

India

Contacts

Public ContactDr Palaniamma

The Himalaya Drug Company

dr.palani@himalayawellness.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026